+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Contract Development & Manufacturing Market by Service Type (Contract Development Services, Contract Manufacturing Services), Development Stage (Clinical, Commercial, Preclinical), End Use, Customer Type - Global Forecast 2025-2030- Product Image
Pharmaceutical Contract Development & Manufacturing Market by Service Type (Contract Development Services, Contract Manufacturing Services), Development Stage (Clinical, Commercial, Preclinical), End Use, Customer Type - Global Forecast 2025-2030- Product Image
Sale

Pharmaceutical Contract Development & Manufacturing Market by Service Type (Contract Development Services, Contract Manufacturing Services), Development Stage (Clinical, Commercial, Preclinical), End Use, Customer Type - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4829832
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical contract development and manufacturing market is transforming as life sciences companies increasingly seek flexible partners to support the rapid evolution of drug pipelines and heightened regulatory expectations. Technological innovation, market fragmentation, and evolving global policies collectively shape strategic planning for senior decision-makers in this dynamic sector.

Market Snapshot: Pharmaceutical Contract Development & Manufacturing

The Pharmaceutical Contract Development & Manufacturing Market grew from USD 136.27 billion in 2024 to USD 148.06 billion in 2025. It is expected to continue growing at a CAGR of 8.49%, reaching USD 222.23 billion by 2030. This sustained growth is driven by rising demand for specialized services, the integration of analytical development and commercial-scale manufacturing, and increasing emphasis on speed and risk mitigation across the pharmaceutical value chain.

Scope & Segmentation

  • Service Types: Contract development services, including analytical development, clinical trial material manufacturing, drug formulation development, and process development; contract manufacturing services, such as API manufacturing, finished dosage form manufacturing, and packaging services.
  • Development Stages: Preclinical, clinical (including Phase I, II, and III), and commercial program support, covering everything from early-stage toxicology to commercial-scale supply chain delivery.
  • End Uses: Applications in oncology, infectious diseases, cardiovascular, and central nervous system therapies, representing high-value and high-demand therapeutic areas.
  • Customer Types: Biosimilar manufacturers, biotechnology companies, generic pharmaceutical firms, and innovator pharmaceutical organizations, each with unique service needs and strategic requirements.
  • Regional Coverage: Americas (with a focus on the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including key markets such as UK, Germany, France, South Africa, Saudi Arabia, Switzerland, among others), and Asia-Pacific (covering China, India, Japan, Australia, and Southeast Asia).
  • Key Technologies: Adoption of digital quality control, single-use bioreactors, continuous manufacturing, modular facility designs, environmentally conscious production, and real-time analytics for process monitoring.

Key Takeaways for Decision-Makers

  • Technological innovation, including single-use technologies and digital process monitoring, is reshaping manufacturing agility and operational excellence. Sponsors increasingly prioritize partners with digitally enabled infrastructures.
  • The growing focus on complex therapeutic modalities such as gene and cell therapies drives demand for highly specialized process development expertise and targeted collaborations.
  • Market fragmentation encourages consolidation as well as niche specialization, resulting in a blend of global leaders and regionally focused innovators offering advanced manufacturing and development capabilities.
  • Diverse customer profiles require customized partnership models and risk-sharing agreements, particularly for early-stage biotechnology and biosimilar development.
  • Regional shifts reflect both cost optimization and regulatory harmonization efforts, with North America emphasizing digital advancement, Europe fostering pan-regional collaboration, and Asia-Pacific expanding API and biologics supply chains.

Tariff Impact: Navigating U.S. Policy Shifts

U.S. tariffs imposed in 2025 on selected chemical intermediates and pharmaceutical components have prompted organizations to review global sourcing and manufacturing strategies. Many companies are moving toward localized procurement, diversifying suppliers, and relocating production closer to end markets to offset increased costs and improve supply chain resilience.

Strategic project planning now includes dynamic cost modelling and scenario analysis to mitigate future trade disruptions, supporting margin integrity and lead time optimization for cross-border pharmaceutical development.

Methodology & Data Sources

This report draws upon rigorous primary and secondary research, including executive interviews, analysis of industry publications, regulatory filings, and patent data. Findings were further validated through an advisory panel of subject-matter experts to ensure the robustness and credibility of market insights.

Why This Report Matters

  • Actionable intelligence highlights emerging growth opportunities, guiding executive decisions on technology investment and partnership strategies.
  • Comprehensive segmentation supports tailored planning for development stage, service offering, and regional expansion.
  • Objective benchmarking supports operational efficiency improvements and supply chain risk assessment.

Conclusion

The pharmaceutical contract development and manufacturing sector demands adaptive, data-driven strategies to maintain competitiveness. Investing in digitalization, regional optimization, and advanced service capabilities positions organizations to navigate evolving market and regulatory complexities with confidence.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Advancements in continuous manufacturing platforms for small molecule API production
5.2. Integration of artificial intelligence for process optimization in biologics development
5.3. Rising demand for personalized medicine driving expansion of customizable fill and finish services
5.4. Regulatory harmonization challenges influencing quality management systems across global CDMO networks
5.5. Strategic partnerships between CDMOs and emerging biotech firms to accelerate novel modality pipelines
5.6. Implementation of digital twin technology to enhance real-time monitoring in drug manufacturing plants
5.7. Expansion of cold chain logistics infrastructure to support growing mRNA and cell therapy supply chains
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Contract Development & Manufacturing Market, by Service Type
8.1. Introduction
8.2. Contract Development Services
8.2.1. Analytical Development
8.2.2. Clinical Trial Material Manufacturing
8.2.3. Drug Formulation Development
8.2.4. Process Development
8.3. Contract Manufacturing Services
8.3.1. Active Pharmaceutical Ingredient (API) Manufacturing
8.3.2. Finished Dosage Form (FDF) Manufacturing
8.3.3. Packaging Services
9. Pharmaceutical Contract Development & Manufacturing Market, by Development Stage
9.1. Introduction
9.2. Clinical
9.2.1. Phase I
9.2.2. Phase II
9.2.3. Phase III
9.3. Commercial
9.4. Preclinical
10. Pharmaceutical Contract Development & Manufacturing Market, by End Use
10.1. Introduction
10.2. Cardiovascular
10.3. Central Nervous System
10.4. Infectious Diseases
10.5. Oncology
11. Pharmaceutical Contract Development & Manufacturing Market, by Customer Type
11.1. Introduction
11.2. Biosimilar Manufacturer
11.3. Biotechnology Company
11.4. Generic Pharma
11.5. Innovator Pharma
12. Americas Pharmaceutical Contract Development & Manufacturing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Pharmaceutical Contract Development & Manufacturing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Pharmaceutical Contract Development & Manufacturing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Lonza Group AG
15.3.3. Catalent Inc.
15.3.4. Recipharm AB
15.3.5. Samsung Biologics Co., Ltd.
15.3.6. WuXi AppTec Co., Ltd.
15.3.7. Boehringer Ingelheim International GmbH
15.3.8. AGC Biologics Inc.
15.3.9. Siegfried Holding AG
15.3.10. Fareva Holding SAS
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: RESEARCHAI
FIGURE 24. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 25. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 26. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL TRIAL MATERIAL MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DRUG FORMULATION DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DRUG FORMULATION DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY FINISHED DOSAGE FORM (FDF) MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY FINISHED DOSAGE FORM (FDF) MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PACKAGING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PACKAGING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHASE I, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHASE I, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHASE II, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHASE II, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHASE III, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PHASE III, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COMMERCIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PRECLINICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY PRECLINICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOSIMILAR MANUFACTURER, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOSIMILAR MANUFACTURER, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY INNOVATOR PHARMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY INNOVATOR PHARMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 101. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 102. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 103. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 104. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 105. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 106. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 107. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 108. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 109. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 110. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 111. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 112. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 113. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 114. CANADA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 115. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 116. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 117. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 118. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 119. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 120. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 121. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 122. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 123. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 124. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 125. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 128. MEXICO PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 187. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 188. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 189. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 190. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 191. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 192. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 193. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 194. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 195. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 196. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 197. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 200. GERMANY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 201. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 202. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 203. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 204. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 205. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 206. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 207. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 208. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 209. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 210. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 211. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 212. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 213. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 214. FRANCE PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 229. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 230. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 231. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 232. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 233. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD MILLION)
TABLE 234. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2025-2030 (USD MILLION)
TABLE 235. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2024 (USD MILLION)
TABLE 236. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY DEVELOPMENT STAGE, 2025-2030 (USD MILLION)
TABLE 237. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2018-2024 (USD MILLION)
TABLE 238. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CLINICAL, 2025-2030 (USD MILLION)
TABLE 239. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2018-2024 (USD MILLION)
TABLE 240. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY END USE, 2025-2030 (USD MILLION)
TABLE 241. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2018-2024 (USD MILLION)
TABLE 242. ITALY PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CUSTOMER TYPE, 2025-2030 (USD MILLION)
TABLE 243. SPAIN PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 244. SPAIN PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 245. SPAIN PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2018-2024 (USD MILLION)
TABLE 246. SPAIN PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT DEVELOPMENT SERVICES, 2025-2030 (USD MILLION)
TABLE 247. SPAIN PHARMACEUTICAL CONTRACT DEVELOPMENT & MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING SERVICES, 2018-2024 (USD

Samples

Loading
LOADING...

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Catalent Inc.
  • Recipharm AB
  • Samsung Biologics Co., Ltd.
  • WuXi AppTec Co., Ltd.
  • Boehringer Ingelheim International GmbH
  • AGC Biologics Inc.
  • Siegfried Holding AG
  • Fareva Holding SAS

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 148.06 Billion
Forecasted Market Value ( USD ) by 2030 $ 222.23 Billion
Compound Annual Growth Rate8.4%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Customer Type, Therapeutic Area, Contract Type, Production Scale, Process Type - Global Forecast 2025-2030 - Product Image

Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Customer Type, Therapeutic Area, Contract Type, Production Scale, Process Type - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Pharmaceutical Contract Manufacturing & Research Services Market by Service Type (Consulting Services, Manufacturing Services, Research Services), End-User (Academic & Government Research Institutes, Biotechnology Companies, Pharmaceutical Companies) - Global Forecast 2025-2030 - Product Image

Pharmaceutical Contract Manufacturing & Research Services Market by Service Type (Consulting Services, Manufacturing Services, Research Services), End-User (Academic & Government Research Institutes, Biotechnology Companies, Pharmaceutical Companies) - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of Operation, Workflow, Application, End Use, Company, and Region with Growth Forecasts, 2025-2030 - Product Image

Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of Operation, Workflow, Application, End Use, Company, and Region with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Generic Pharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis Report By Drug Type (Branded, Unbranded), By Product (API, Drug Product), By Route Of Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Generic Pharmaceuticals Contract Manufacturing Market Size, Share & Trends Analysis Report By Drug Type (Branded, Unbranded), By Product (API, Drug Product), By Route Of Administration, By Application, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application (Therapeutic, Research, Diagnostic), End User (Pharma, Biotech) - Global Forecast to 2029 - Product Image

Oligonucleotide CDMO Market by Service (Contract Manufacturing (Clinical, Commercial), Development), Type (ASO, SiRNA, (CPG Oligos, gRNA)), Application (Therapeutic, Research, Diagnostic), End User (Pharma, Biotech) - Global Forecast to 2029

  • Report
  • 255 Pages
  • Global
From

About the Pharmaceutical Contract Management Market

The Pharmaceutical Contract Management market is an important part of the drug discovery process. It involves the management of contracts between pharmaceutical companies and research organizations, such as universities and biotechnology companies. These contracts are used to facilitate the development of new drugs and treatments. The contract management process includes the negotiation of terms, the management of payments, and the tracking of progress. It also involves the management of intellectual property rights, such as patents and copyrights. The Pharmaceutical Contract Management market is highly competitive, with many companies offering services to pharmaceutical companies. These companies provide a range of services, including contract negotiation, contract management, and intellectual property management. Some of the leading companies in the market include Accenture, Deloitte, Parexel, and Syneos Health. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.